HR
QTTB icon

Howe & Rusling’s Q32 Bio QTTB Stock Holding History

Howe & Rusling’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-4
Closed – – 1212
2022
Q2 		$0 Buy
+4
New +$137 ﹤0.01% 1179

Other funds holding QTTB

Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Howe & Rusling's QTTB Position: Q3 2022 in Review

Howe & Rusling sold out of Q32 Bio (QTTB) in Q3 2022, closing a stake of 4 shares.

Howe & Rusling first reported a position in QTTB in Q2 2022 and held it in 1 quarter. The position peaked at $0 in Q2 2022. 83 funds tracked by Wall St. Rank hold QTTB as of Q3 2022.

  • Howe & Rusling reported no remaining Q32 Bio position as of Q3 2022 after selling out during the quarter.
  • Howe & Rusling sold 4 Q32 Bio shares in Q3 2022.
  • Howe & Rusling first reported a position in Q32 Bio in Q2 2022 and held it in 1 quarter.
  • Howe & Rusling's Q32 Bio position peaked at $0 in Q2 2022.
  • 83 funds tracked by Wall St. Rank held Q32 Bio as of Q3 2022.

Based on Howe & Rusling's 13F filing for Q3 2022, filed 14 Nov 2022.